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Design choices related to development of data-
driven models significantly impact or degrade 
predictive performance of the models. One of the 
essential steps during development and evaluation of 
such models is the choice of feature selection and 
dimension reduction techniques. That is imperative 
especially in cases dealing with multimodal data 
gathered from different sources. In this paper, we will 
investigate the behavior of Partial Least Squares (PLS) 
regression for dimension reduction and prediction of 
motor states of Parkinson’s disease (PD) patients, 
using upper limb motor data gathered by means of a 
smartphone. The results in terms of correlations 
between smartphone-based and clinician-derived 
scores were compared to a previous study using the 
same data where principal component analysis (PCA) 
and support vector machines (SVM) were used. The 
findings from this study show that PLS is superior in 
terms of prediction performance of motor states in PD 
than combining PCA and SVM. This indicates that PLS 
could be considered as a useful methodology in 
problems where data-driven analysis is needed. 
 
1. Introduction  
 
Given a training set of explanatory variables and 
the associated response variable, machine learning 
methods try to predict accurately and automatically the 
response variable. Machine learning tasks where the 
number of features (explanatory variables) is much 
larger than the number of observations are becoming 
more and more common [1]. The inferred machine 
learning methods are expected to produce “decisions” 
based on multivariate representations, which in turn 
provide complementary information during decision-
making process of the methods. On the other hand, the 
high dimensionality can negatively impact the 
predictive performance of the machine learning 
methods by increasing the risk of overtraining. In order 
to reduce the effects of high dimensionality while 
retaining the most relevant information, dimension 
reduction and feature selection techniques are usually 
recommended. The main aim of feature selection and 
dimension reduction techniques is to use a selected 
subset of features that significantly contributes to 
measuring the response variable as well as eliminate 
those features which are non-informative for the 
problem at hand. Unfortunately, there is no systematic 
approach to choosing the most suitable feature 
selection and dimension reduction technique to be used 
along with machine learning methods. The best 
approach is to base the design choices in knowledge 
from comparative studies and also perform a wide 
range of experiments. 
The step of defining the optimal choice of feature 
selection methods is essential in studies aiming at 
developing and evaluating sensor-based systems in 
healthcare applications. One such example is the need 
for objective assessment of motor symptoms in 
Parkinson’s disease (PD). Since PD itself is 
considerably individual where there is a large variation 
in manifestation of clinical symptoms new technology-
based objective measures should include multiple 
modalities [2, 3]. Multimodal analysis includes data 
from different sensors with the aim of finding the 
relationships between multimodal data and different 
groups of patients in order to identify patient 
trajectories as well as provide means for optimal 
tailoring of treatments based on individual patient 
profiles [3]. There are several studies reporting results 
on objective measures in PD using multimodal data 
including combination of speech, handwriting, and gait 
[4], voice, posture, gait, finger tapping, and response 
time [5], leg agility, sit-to-stand, and gait tasks [6], and 
daily motion patterns, freezing of gait, among others 
[7]. Combining data from multiple modalities or even 
extracting multiple variables from a single modality 






poses challenges during development of data-driven 
models for measuring the severity of the symptoms.  
For building data-driven models, different design 
choices should be made during the whole process chain 
including data collection scheme, data processing and 
analysis, and interpretation, each of which equally 
contribute to the predictive performance and 
generalizability of the data-driven models. With the 
expansion of wearable sensors data, the methods that 
can address the multidimensionality and collinearity of 
high frequency and high dimensional datasets must be 
employed [8]. This is essential for determining the 
clinimetric properties such as test-retest reliability, 
internal consistency, and responsiveness to treatment 
interventions of the sensor-based systems. In order to 
achieve this, the scores derived from such systems 
should be mapped to and evaluated against “gold 
standard” outcome measures used in clinical trials. In 
PD, assessment of both motor and non-motor 
symptoms is usually done with clinical rating scales 
e.g. Unified PD Rating Scale (UPDRS). However, its 
application is not practical since it requires 
involvement of a clinical staff and is subject to inter-
rater variability. Applying sensors technology coupled 
with machine learning is an emerging approach for 
diagnosing the disease earlier and measuring motor 
symptoms and fluctuations both during home and long-
term monitoring [9]. According to Rovini et al. [9], the 
most commonly used methods are different machine 
learning approaches like support vector machines 
(SVM), decision trees, k-nearest neighbor, random 
forests, among others, for classification and regression 
and principal component analysis (PCA) for dimension 
reduction and feature selection. 
In this paper, we aim at investigating the behavior 
of Partial Least Squares (PLS) regression for 
dimension reduction and prediction in terms of the 
influence on prediction performance. For this work, a 
dataset from a clinical study where upper limb motor 
data (spiral drawing and tapping tests) of PD patients 
was gathered by a smartphone [10]. The aim is to 
develop a data-driven model for assessing motor states 
of the patients and to determine the appropriate design 
choices for such a model. This experimental work 
contributes to the field by providing a comparison of 
the predictive performance between PLS and a 
previous methodology [11] based on PCA for 





2.1. Data and experimental setup 
 
For this work, a dataset from a clinical study where 
individuals with advanced PD (n=19, 5 females) and 
control participants (n=22, 6 females) were recruited 
was used [10]. The patients had mean age of 71.4 years 
with mean years living with PD of 9.7. The study was 
performed at the Uppsala University Hospital, Sweden. 
The clinical study was approved by the regional ethical 
committee and all participants provided informed 
consent.  
The patients received 150% of their individual 
levodopa-carbidopa equivalent morning dose. All 
participants repeatedly performed standardized motor 
tasks according to the motor (part III) section of the 
UPDRS including UPDRS #23 (finger tapping), 
UPDRS #25 (rapid alternating movements of hands), 
and UPDRS #31 (bradykinesia) [12]. Patients repeated 
the assessments up to 15 times starting from baseline 
where there was no medication (around 20 minutes 
prior to dosing to the time of dose administration, 0 
minutes) and follow-up times till 360 minutes after 
dose administration. The healthy controls repeated the 
assessments maximum 8 times starting from the first 
test (0 minutes) to the last one (around 170 minutes), 
without receiving any medication. 
The smartphone application prompted the 
participants to perform the following upper limb motor 
tests: 1) alternating tapping with the right hand, 2) 
alternating tapping with the left hand, and 3) spiral 
drawing with dominant hand. The tests were performed 
while the patients were seated on a chair with the 
device placed on a table and using an ergonomic pen 
stylus.  
During tapping tests, the patients alternately tapped 
two fields, as shown on the screen of the device, as fast 
and accurate as possible. The time to complete the 
tapping tests was 20 seconds.  
For the spiral drawing test, the patients were asked 
to trace a pre-drawn Archimedes spiral as fast and 
accurately as possible, from the center out within 10 
seconds. The spiral drawing test was repeated 3 times 
per test occasion.  
The smartphone application had a 4” touch screen 
with a 480 X 800 pixels and recorded position (x and y 
coordinates) and time-stamps (in milliseconds) of the 
pen tip. 
Before starting the data collection all participants 
were trained on how to use the smartphone and 
perform the motor tests. While the patients performed 
the UPDRS-related tasks and upper limb motor tests on 
the smartphone at the above-mentioned time points 
they were also video recorded. The videos were 
presented in a randomized order to three movement 
disorder specialists in order to get ratings blinded with 
respect to time from dose administration. The three 
UPDRS-related items and dyskinesia [13] were rated 
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on a scale from 0 (normal) to 4 (extremely severe). 
Additionally, the specialists rated the overall mobility 
of the patients on a Treatment Response Scale (TRS) 
ranging from -3 (very Off) to 0 (On) to +3 (very 
dyskinetic) [14]. For all these scales, mean scores of 
the three specialist per time point were calculated and 
used in subsequent analysis. 
 
2.2. Analysis of smartphone data 
 
A range of summary features were extracted to 
quantify the motor performance of the patients during 
the upper limb motor tests. In total, there were 37 
features that were extracted from smartphone-gathered 
data during tapping and spiral drawing tests. The 
complete list of features and their corresponding 
methodologies can be found elsewhere [11], however 
an outline of them is provided as following. 
Initially, signals related to kinematic quantities 
such as time, spatial distance, drawing speed, and 
drawing velocity were extracted and used in time- and 
wavelet-domain methods.  
For tapping tests, the position of pen on the screen 
(x and y coordinates), timestamp, and an indicator 
whether a field was missed or not were recorded by the 
smartphone. Using these data, 20 summary features 
were developed including total number of taps per test, 
mean tapping time difference between two fields, mean 
tapping speed from left field to right field and vice 
versa, mean distance from the centers of the fields, 
overall distribution of the taps per field and test, 
approximate entropy (ApEn) of the first and second 
part of the time series signal, ApEn of mean tapping 
speed, etc. The individual features for both hands were 
averaged and used in subsequent analysis.  
For spiral drawing tests, the smartphone recorded 
the position of the pen as well as the timestamp. From 
these data, 17 features were extracted including mean 
drawing speed, coefficient of variation (CV) of speed, 
radial velocity, ApEn of drawing speed and radial 
velocity, CV of high frequency derived by discrete 
wavelet coefficients (DWT), kurtosis of drawing 
speed, etc. The features for the 3 spiral trials were 
averaged and used in subsequent analysis.  
 
2.3. Prediction of motor states using PCA and 
SVM 
 
For predictive modelling, the spatiotemporal 
features from both tapping and spiral motor tests were 
then used in PCA to reduce their dimensions and keep 
a smaller number of predictors as inputs to SVM. After 
PCA, seven principal components were retained and 
used in machine learning procedure [11]. 
 
2.4. Prediction of motor states using PLS 
 
When dealing with multivariate models the aim is 
to determine the subset of variables (features) that 
account for most of the variation measured by the 
response variable. In order to determine a small and 
relevant subset of features, which would explain the 
strongest effect in relation to the response variable that 
is mean clinical ratings on the TRS scale PLS 
regression was employed. The PLS transfers the 
feature data into latent variables (factors) to reduce the 
dimensionality of the features followed by employing a 
multiple linear regression on latent variables. For this 
process, all the 37 features were used as inputs to PLS 
to be mapped to mean TRS. The PLS retains a subset 
of features in order to provide a more interpretable 
model with lower predictive error as compared to the 
model using all the 37 features. The aim of the PLS 
was to predict the mean TRS by using the fitted model. 
From the explanatory variables the PLS extracted the 
latent variables that accounted for most of the variation 
in the mean TRS.  
The retained factors were then used as explanatory 
variables in a regression model with continuous mean 
TRS as response. Two separate PLS models were built. 
One was built using only the patient data with the aim 
of predicting the mean TRS. The second model was 
built using both the patients and healthy controls data 
with the aim of classifying PD patients from healthy 
controls. 
 
2.5. Statistical analysis 
 
Pearson correlation coefficients were calculated 
between the scores produced by the proposed approach 
using PLS, previous approach based on PCA and SVM 
[11], and the clinical mean TRS. To assess the 
responsiveness to treatment intervention of the scores 
their summary statistics (mean ± standard error) over 
the time points during the single levodopa dose 
challenge were investigated. The ability of the PLS-
derived factors to discriminate between the motor 
states and tests performed by healthy controls and 





3.1. Determining the number of factors 
 
Nine factors were retained from the PLS analysis. 
These 9 factors explained 72% of the variation in the 
response variable i.e. mean TRS (Table 1). The factors 
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1 and 2 had the highest variation in the response 
variables with 17% and 16% respectively. Factor 
loadings for factor 1 were shown to be primarily 
characterized by high values of the individual features 
including absolute mean difference between the first 
and second part of the time series (tapping test), overall 
trend of tapping reaction time (tapping test), and CV of 
high frequency wavelet coefficients by DWT (spiral 
drawing test). Factor 2 was characterized by high 
values of CV of distances from the center fields 
(tapping test), overall distribution of taps (tapping test), 
mean tapping speed per cycle (tapping test), amount of 
irregularity in vertical tap distance (tapping test), 
irregularity in time (tapping test), and global maxima 
of drawing speed (spiral drawing test). 
  
 Current Total 
Factor 1 0.17 0.17 
Factor 2 0.16 0.33 
Factor 3 0.08 0.41 
Factor 4 0.09 0.5 
Factor 5 0.06 0.56 
Factor 6 0.05 0.61 
Factor 7 0.04 0.65 
Factor 8 0.03 0.68 
Factor 9 0.04 0.72 
Table 1. Explained variation in mean TRS 
derived from PLS analysis of 37 
spatiotemporal features extracted from the 
smartphone upper limb motor data. 
3.2. Correlations to clinical ratings 
 
Using the 9 factors as explanatory variables the 
PLS could predict the mean TRS with a correlation 
coefficient of 0.75. The predicted scores are hence on 
denoted as TRS-PLS. The score produced by the 
previous approach that used PCA for dimension 
reduction and SVM for numerical prediction was 
correlated with the mean TRS with a coefficient of 
0.59 [11], indicating a lower predictive performance 
than TRS-PLS. 
The TRS-PLS correlated well with UPDRS #31 
(bradykinesia) with an absolute coefficient of 0.7 (vs. 
0.57), with dyskinesia with 0.63 (vs. 0.64), and with 
sum of the three UPDRS item with 0.48 (vs. 0.46). 
Low correlations were found between TRS-PLS and 
UPDRS #23 (finger tapping), and UPDRS #25 (rapid 
alternating movements of hands) with coefficients of 
0.19 and 0.26, respectively. All correlation coefficients 
were significant at .001 level. Figure 1 shows the mean 
(± standard error) of mean clinical TRS and TRS-PLS, 
indicating an an ability of the TRS-PLS to capture 
changes in motor states during the single dose 
levodopa challenge i.e. the transition between baseline 
(no medication), peak medication effect, possibly, 
associated with dyskinesias (involuntary movements) 
and transition back to the wearing-Off state associated 
with Parkinsonian symptoms.  
 
 
Figure 1. Mean (± standard error) of mean 
clinical TRS (blue line) and TRS-PLS (orange 
line) over the single levodopa dose cycle. 
3.3. Classification of motor states 
 
The data from the patients were pooled into 2 
categories: Off and dyskinesia. This was done on the 
basis of the mean TRS ratings by applying the 
following criteria. The Off group contained all the 
observations with a mean TRS <0.5. The rest were 
categorized as dyskinesia. Figure 2 shows mapping of 
the two factors derived from the PLS method in 
relation to the 2 categories. A clear distinction between 
the two classes is missing. Nevertheless, majority of 
the observations could be correctly classified with this 
model. However, a part of them from the two 
categories were misclassified as the opposing category. 
 
3.4. Unsupervised classification of motor states 
 
The second PLS model used the data from both PD 
patients and healthy controls. The original 37 features 
were used as explanatory variables and the indicated 
group (healthy control or patient) as a response 
variable. Examining the two factors of the model 
showed that the features derived from the upper limb 
motor tests contained sufficient information to 
distinguish tests performed by patients from those 
performed by healthy controls (Figure 3). However, 
there was a clear overlap between the two categories 
representing the misclassified observations. 
 
4. Discussion  
 
In this experimental work, a model based on PLS 
was introduced and studied on a smartphone-based 
data of PD patients. The model was built using 37 
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spatiotemporal features extracted from upper limb 
motor tests like tapping and spiral drawing tests that 
were then mapped to a clinical reference on the TRS 
scale to produce a score called TRS-PLS. The 
predictive performance of the new approach has been 
evaluated in relation to a previous methodology based 
on PCA and SVM [11]. The results from the study 
show superior predictive performance of TRS-PLS as 
compared to the previous methodology. 
 
 
Figure 2. Scatterplot of the first two factors 
derived from the PLS analysis. Data points 
are labelled with the two categories: Off and 
dyskinesia. 
 
Figure 3. Scatterplot of the first two factors 
derived from the PLS analysis. Data points 
are labelled with the two groups: HC 
(healthy control) and PD patient. 
Using PLS, an improvement in predictive 
performance in terms of correlation coefficients to the 
clinical TRS was observed. The PLS-TRS had a higher 
correlation coefficient (0.75) as compared to the 
approach using PCA and SVM that had a correlation 
coefficient of 0.59. Similar to our previous studies [15] 
where the effects of feature selection methods (e.g. 
stepwise regression, Lasso regression) and PCA on the 
performance of machine learning methods were 
investigated, in this study we found that using PLS for 
reducing dimensions of spatiotemporal features and 
using its factors for prediction provided the best 
predictive performance. 
The TRS-PLS correlated well with clinical 
assessments of bradykinesia (slowness of movements) 
and moderately to dyskinesia (involuntary, 
uncontrolled movements), which were separately rated 
by the movement disorder specialists, with coefficients 
of 0.7 and 0.63, respectively. Since the correlation 
coefficient to dyskinesia was lower than that to 
bradykinesia, it can be concluded that the TRS-PLS 
contains symptom information relevant to mainly 
capture bradykinesia and not dyskinesia. This could 
also be observed in Figure 2 where the TRS-PLS had a 
similar trend as the clinical TRS over the course of the 
single levodopa cycle during the day indicating ability 
of the proposed methodology to capture changes 
between the motor states. Nevertheless, the mean TRS-
PLS was less responsive than clinical TRS in terms of 
capturing peak dyskinesias i.e. above 0 on the scale 
from -3 to +3 scale. The limitation to not be able to 
detect dyskinesias can be related due to the fact that 
majority of the cases were in the range between -2 
(moderately Off) to 1 (slightly dyskinetic) and the 
considerable amount of variability in ratings between 
the 3 movement disorder experts. This could impact 
the ability of the proposed methodology to predict 
cases outside of this range. 
Using unsupervised methods is desirable in cases 
where there is no clear benchmark/“gold standard”, a 
common situation when collecting real-world data 
using sensors technology. In PD-related clinical trials, 
the gold standard is mainly based on ratings provided 
by movement disorders specialists and history taking. 
Since the rating itself is based on subjective ratings of 
the clinicians, which in turn is influenced by their 
clinical experience and intuition there is a need for 
developing data-driven models without the presence of 
clinical labels. For these reasons, the use of PLS-
derived factors was explored to classify tests 
performed by patients from those performed by healthy 
controls. The factors could relatively separate the two 
groups (Off and dyskinesia) from each other. There 
was a sizable minority from the two groups that were 
misclassified. These results could indicate a 
discriminating power of the PLS to capture movements 
during the upper limb motor tests related to different 
motor states. 
After examining factor loadings of the individual 
features indicated that the features extracted from the 
tapping tests had more predictive information than the 
features from the spiral drawing tests. This was 
expected since the finger tapping tests have been 
previously shown to be good at measuring motor 
performance related to Off symptoms [16]. The second 
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PLS model was able to classify tests performed by the 
patients from those performed by healthy controls, as 
shown in Figure 3. The classification was done in an 
unsupervised manner and this is a strength of the 
proposed method. 
The predictive performance of PLS was assessed in 
previous studies and, similar to our results, application 
of PLS seems to be an advantageous approach due to 
its ability to reduce collinearity and perform numerical 
prediction. For instance, in a comparative study [17] 
PLS was compared to principal component regression, 
ridge regression, and ordinal least squares. The PLS 
outperformed the rest of the methods when applied to a 
dataset related to gross domestic product. Similar 
results were derived by combining PLS and SVM for 
predicting bankruptcy in a study performed by Yang et 
al. [18].  
A limitation of the study is the unbalanced sample 
size in terms of equal number of observations per each 
category of the TRS scale, which was used as a 
dependent variable. This limitation could impact the 
ability of the TRS-PLS to capture dyskinesias since 
such cases were underrepresented in the dataset. The 
TRS-PLS should be further evaluated with data 
gathered on a new population of patients, (e.g. [19]). 
Future research would also include comparison of 
feature selection and machine learning methods with 
PLS in terms of predictive performance using 
multimodal data in PD gathered during other 
standardized motor tasks e.g. gait [20], alternating 
movements of hands [21], and leg agility [22]. 
 
6. Conclusions  
 
In summary, employing PLS in the smartphone 
data was shown to be more effective as compared to 
combining PCA and SVM in objective characterization 
of PD motor states. In contrast to PCA and SVM, PLS 
seemed to have better predictive performance due to its 
ability to minimize the collinearity among the multiple 
spatiotemporal features and also perform a numerical 
prediction. PLS-derived scores had higher correlations 
to clinical ratings as well as showed discriminating 
power during unsupervised classification of PD 
patients from healthy controls. The results should be 
further investigated in other studies with new 
population data, not necessarily, generated from 
healthcare domain. 
 
7.  Acknowledgements 
 
This work has been supported by funds from the 
Swedish Knowledge Foundation and Swedish Agency 
for Innovation (Vinnova). 
8.  References 
[1] P. Drotar, J. Gazda, and Smekal, Z, “An experimental 
comparison of feature selection methods on two-class 
biomedical datasets”, Computers in Biology and Medicine, 
Elsevier, 2015, pp. 1-10. 
 
[2] A.J. Espay, P. Bonato, F.B. Nahab, W. Maetzler, J.M. 
Dean, J. Klucke, et al., “Technology in Parkinson’s disease: 
challenges and opportunities” Movement Disorders, Wiley, 
2016, pp. 1272-1282. 
 
[3] J. Klucken, R. Kruger, P. Schmidt, and B.R. Bloem, 
”Management of Parkinson’s disease 20 from now: towards 
digital health pathways”, Journal of Parkinson’s Disease, IOS 
Press, 2018, pp. S85-S94. 
 
[4] J.C. Vasques-Correa, T. Arias-Vergara, J.R. Orozco-
Arroyave, B. Eskofier, J. Klucken, and E. Nöth, “Multimodal 
assessment of Parkinson’s disease: a deep learning approach” 
IEEE Journal of Biomedical and Health Informatics, IEEE, 
2019. 
 
[5] S. Arora, V. Venkataraman, A. Zhan, S. Donuhue, K.M. 
Biglan, E.R Dorsey, and M.A. Little, “Detecting and 
monitoring the symptoms of Parkinson’s disease using 
smartphones: a pilot study” Parkinsonism & Related 
Disorders, Elsevier, 2015, pp. 650-653. 
 
[6] F. Parisi, G. Ferrari, M. Giuberti, L. Contin, V. Cimolin, 
C. Azzaro, et al., “Body sensor network-based kinematic 
characterization and comparative outlook of UPDRS scoring 
in leg agility, sit-to-stand, and gait tasks in Parkinson’s 
disease” IEEE Journal of Biomedical and Health Informatics, 
IEEE, 2015, pp. 1777-1793. 
 
[7] F. Alvarez, M. Popa, V. Solachidis, G. Hernandez-
Penaloza, A. Nelmonte-Hernandez, S. Asteriadis, et al., 
”Behaviour analysis through multimodal sensing for care of 
Parkinson’s disease and Alzheimer’s patients” IEEE 
Multimedia, IEEE, 2018, pp. 14-25. 
 
[8] K.J. Kubota, J.A. Chen, and M.A. Little, “Machine 
learning for large-scale wearable sensor data in Parkinson’s 
disease: concepts, promises, pitfalls, and futures” Movement 
Disorders, Willey, 2016, pp. 1314-1326. 
 
[9] E. Rovini, C. Maremmani, and F. Cavallo, “How 
wearable sensors can support Parkinson’s disease diagnosis 
and treatment: a systematic review”, Frontiers in 
Neuroscience, Frontiers, 2017. 
 
[10] M. Senek, S.M. Aquilonius, H. Askmark, F. Bergquist, 
R. Constantinescu, A. Ericsson, et al., “Levodopa/carbidopa 
microtablets in Parkinson’s disease: a study of 
pharmacokinetics and blinded motor assessment”, European 
Journal of Clinical Pharmacology, Springer, 2017, pp. 563-
571. 
 
[11] S. Aghanavesi, D. Nyholm, M. Senek, F. Bergquist, and 
M. Memedi, “A smartphone-based system to quantify 
Page 1061
  
dexterity in Parkinson’s disease patients”, Informatics in 
Medicine Unlocked, Elsevier, 2017, pp. 11-17. 
 
[12] P. Martinez-Martin, C. Rodriguez-Blazques, M. 
Alvarez, T. Arakaki, C. Arillo, P. Chana, et al., “Parkinson’s 
disease severity levels and MDS-Unified Parkinson’s Disease 
Rating Scale”, Parkinsonism & Related Disorders, Elsevier, 
2015, pp. 50-54. 
 
[13] C.G. Goetz, J.G Nutt, and G.T Stebbins, “The unified 
dyskinesia rating scale: presentation and clinimetric profile” 
Movement Disorders, Willey, 2008, pp. 2398-2403. 
 
[14] D. Nyholm, R.A. Nilsson, N. Dizdar, R. Constantinescu, 
B. Holmberg, et al., “Duodenal levodopa infusion 
monotherapy vs oral polypharmacy in advanced Parkinson’s 
disease” Neurology, Wolters Kluwer, 2005, pp. 216-223. 
 
[15] F. Javed, I. Thomas, and M. Memedi, “A comparison of 
feature selection methods when using motion sensors data: a 
case study in Parkinson’s disease”, Conference Proceedings 
of the IEEE Engineering in Medicine and Biology Society, 
IEEE, 2018. 
 
[16] J.W. Kim, J.H. Lee, Y. Kwon, C.S. Kim, G.M. Eom, 
S.B. Koh, et al., “Quantification of bradykinesia during 
clinical finger taps using a gyrosensor in patients with 
Parkinson’s disease”, Medical and Biological Engineering 
and Computing, Springer, 2011, pp. 365-371. 
 
[17] Ö. Yeniay, and A. Göktas, “A comparison of partial 
least squares regression with other prediction methods, “ 
Hacettepe Journal of Mathematics and Statistics, Hacettepe 
University, 2002, pp. 99-111. 
 
[18] Z. Yang, W. You, and G. Ji, “Using least squares and 
support vector machines for bankruptcy prediction”, Expert 
Systems with Applications, Elsevier, 2011, pp. 8336-8342. 
 
[19] D. Johansson, I. Thomas, A. Ericsson, A. Johansson, A. 
Medvedev, M. Memedi, et al., “Evaluation a sensor 
algorithm for motor state rating in Parkinson’s disease”, 
Parkinsonism & Related Disorders, Elsevier, 2019. 
 
[20] I. Thomas, F. Bergquist, R. Constantinescu, D. Nyholm, 
M. Senek, and M. Memedi, “Using measurements from 
wearable sensors for automatic scoring of Parkinson’s motor 
states: results from 7 patients”, Conference Proceedings of 
the IEEE Engineering in Medicine and Biology Society, 
IEEE, 2017. 
 
[21] I. Thomas, J. Westin, M. Alam, F. Bergquist, D. 
Nyholm, M. Senek, et al., “A treatment-response index from 
wearable sensors for quantifying Parkinson’s disease motor 
states”, IEEE Journal of Biomedical and Health Informatics, 
IEEE, 2018, pp. 1341-1349. 
 
[22] S. Aghanavesi, F. Bergquist, D. Nyholm, M. Senek, and 
M. Memedi, “Motion sensor-based assessment of 
Parkinson’s disease motor symptoms during leg agility tests: 
results from levodopa challenge”, IEEE Journal of 
Biomedical and Health Informatics, IEEE, 2019.
 
Page 1062
